Objective: Glucose-stimulated insulin secretion in pancreatic beta cells requires metabolic signals including the generation of glucose-derived short chain acyl-CoAs in the cytosol from mitochondrially-derived metabolites. One concept of insulin secretion is that ATP citrate lyase generates short chain acyl-CoAs in the cytosol from mitochondrially-derived citrate. Of these, malonyl-CoA, is believed to be an important signal in insulin secretion. Malonyl-CoA is also a precursor for lipids. Our recent evidence suggested that, in the mitochondria of beta cells, glucose-derived pyruvate can be metabolized to acetoacetate that is exported to the cytosol and metabolized to the same short chain acyl-CoAs and fatty acids that can be derived from citrate. We tested for redundancy of the citrate pathway. Methods: We inhibited ATP citrate lyase activity using hydroxycitrate as well as studying a stable cell line generated with shRNA knockdown of ATP citrate lyase in the pancreatic beta cell line INS-1 832/13. Results: In both instances glucose-stimulated insulin release was not inhibited. Mass spectrometry analysis showed that the flux of carbon from [U- C labeling into acetyl-CoA, malonyl-CoA, and HMG-CoA under both conditions. Glucose flux into fatty acids was not affected by ATP citrate lyase knockdown.
INTRODUCTION
In addition to ATP production, an important role of mitochondria in the pancreatic beta cell is anaplerosis, which is the net synthesis of citric acid cycle intermediates that are exported to the cytosol where they are converted to numerous other metabolites that stimulate and/or support insulin secretion. Among these cytosolic products derived from mitochondrial metabolites are short chain acyl-CoAs, such as acetyl-CoA, malonyl-CoA, acetoacetyl-CoA and HMG-CoA [1e15]. Short chain acyl-CoAs are produced inside mitochondria, but cells are unable to transport them across the mitochondrial inner membrane. In order for a cell to provide short chain acyl-CoAs to the cytosol, they are converted to metabolites in the mitochondria that can be exported to the cytosol where they are converted back to short chain acyl-CoAs. During glucose-stimulated insulin secretion in pancreatic beta cells, including human pancreatic islets, short chain acyl-CoAs can be derived from pyruvate in mitochondria by two different pathways. Pyruvate can be metabolized through pyruvate carboxylase to oxaloacetate and through pyruvate dehydrogenase to form acetyl-CoA. Oxaloacetate and acetyl-CoA can combine to form citrate in the citrate synthase reaction in the mitochondria. Citrate is then exported out of the mitochondria to the cytosol where ATP citrate lyase (ACLY) catalyzes citrate's conversion into both oxaloacetate and acetyl-CoA [5, 6] . Cytosolic acetyl-CoA can be carboxylated by acetyl-CoA carboxylase (ACC) to form malonyl-CoA, which can itself act as a signal or be used for fatty acid synthesis. Cytosolic acetyl-CoA can also be converted to acetoacetyl-CoA and HMG-CoA.
In a second biosynthesis pathway, the acetoacetate pathway, that also originates in mitochondria, pyruvate can be converted to acetyl-CoA catalyzed by pyruvate dehydrogenase in the mitochondria. Two acetyl-CoA molecules can combine to form acetoacetyl-CoA. Acetoacetyl-CoA can be converted into acetoacetate by succinyl-CoA:3-ketoacid-CoA transferase (SCOT) and transported out of the mitochondria to the cytosol where it is converted to acetoacetyl-CoA by acetoacetyl-CoA synthetase [9e16] . Cytosolic acetoacetyl-CoA can then be converted to cytosolic acetyl-CoA and malonyl-CoA and HMGCoA as well as fatty acids. There are several reports that knockdown of ATP citrate lyase with siRNA technology in beta cells does not impair glucose-stimulated insulin release [15, 17] while the inhibition of SCOT [15] or acetoacetyl-CoA synthetase [15] does lower insulin release suggesting that the formation of short chain acyl-CoAs through acetoacetate is important during insulin secretion. a-Ketoisocaproic acid (KIC), which stimulates insulin release by itself, is used experimentally to study insulin secretion. KIC is the first intermediate in leucine metabolism. Leucine is the only other normal physiologic stimulator of insulin secretion besides glucose. Both KIC and leucine form substantial amounts of acetoacetate that can exit the mitochondria and increase the levels of short chain fatty acyl-CoAs in the cytosol [14] . To understand the relative contribution of the pathway involving ATP citrate lyase versus the acetoacetate pathway in generating cytosolic short chain acyl-CoAs in insulin secretion, we used 13C-labeled glucose and KIC and monitored 13C flux into short chain acyl-CoAs in the INS-1 832/13 cell line, a cell line of homogeneous pancreatic beta cells in which we decreased ATP citrate lyase enzyme activity. We lowered ATP citrate lyase enzyme activity with hydroxycitrate, an inhibitor of with ATP citrate lyase or used an ATP citrate lyase knockdown cell line generated from INS-1 832/13 cells using shRNA technology [15] . Flux of 13 C glucose into fatty acids was also monitored as a final end product of cytosolic acetyl-CoA and malonyl-CoA.
MATERIALS AND METHODS

Materials [U-
13
C 6 ]a-Ketoisocaproic was purchased from Cambridge Isotopes (Cambridge, MA, USA). All other chemicals were purchased from SigmaeAldrich in the highest purity available unless otherwise mentioned. INS-1 832/13 cells were from Chris Newgard [18] 2.2. Cell culture The ATP citrate lyase knockdown cell line ACLY-940-12 and the control cell line with a scrambled shRNA (U6) were generated from the INS-1 832/13 cell line as previously described. The ACLY 940-12 cell line was one of four stable shRNA ATP citrate lyase knockdown cell lines that previously showed strong knockdown of ATP citrate lyase enzyme activity and no inhibition of glucose-stimulated insulin release [15] . Cells were maintained in RPMI 1640 tissue culture medium (contains 11.1 mM glucose) supplemented with 2 mM glutamine, 1 mM sodium pyruvate, 10% fetal bovine serum, 10 mM HEPES buffer, 100 units/ml penicillin, 100 mg/ml streptomycin, 250 ng/ml amphotericin B, and 50 mM b-mercaptoethanol (INS-1 medium). Hygromycin-B 150 mg/ml was used for continual selection of the ACLY 940-12 and U6 cell lines. For metabolomics experiments, cells were cultured in 6 cm tissue culture plates until the cells were 80% confluent. Cells were then maintained for 6 h in RPMI 1640 medium modified to contain 3 mM glucose (with fetal bovine serum, sodium pyruvate, HEPES buffer and b-mercaptoethanol) before replacing the medium with KrebseHenseleit solution (KRHB) containing no glucose [19] for another 30 min. This 30 min pre-incubation was followed by stimulation with 10 mM uniformly 13 citrate lyase 28e45% and showed no effect on glucose-stimulated insulin release or on the levels and incorporation of 13 C into malate, citrate, acetyl-CoA, and malonyl-CoA (data not shown). Therefore, further studies were carried out with higher concentrations of hydroxycitrate. Figure 1 shows that although 0.5 mM, 1 mM, and 2 mM concentrations of hydroxycitrate inhibit ATP citrate lyase enzyme activity in the cytosol of INS-1 832/13 cells at the most by 73%, the same concentrations of hydroxycitrate do not inhibit glucose-stimulated insulin release from these cells. In a separate experiment not shown here, we found that 10 mM hydroxycitrate inhibited ATP citrate lyase enzyme activity by no more than 60%. To study the flux of glucose into metabolites INS-1 832/13 cells were incubated with concentrations of hydroxycitrate of 0.5 mM, 1 mM, and 2 mM starting 30 min before and continuing for another 30 min after 10 mM [U- 13 C]glucose was added to the cells (Figure 2A ). Measurements of the intracellular concentration of hydroxycitrate showed that it was increased ( Figure 2A ). If the only pathway for the formation of short chain acyl-CoA in pancreatic beta cells requires ATP citrate lyase, its inhibition by hydroxycitrate should decrease the conversion of citrate into acetyl-CoA and oxaloacetate that is converted into malate in the cytosol ( Figure 2A ). All concentrations of hydroxycitrate showed a minimal effect on flux of glucose into citrate and malate ( Figure 2B and C). Importantly, hydroxycitrate showed no effect on the increase in the þ2 isotopomer of both acetyl-CoA and malonyl-CoA ( Figure 2D and E). This þ2 labeling begins with the formation of acetyl-CoA from glucose-derived pyruvate in the pyruvate dehydydrogenase reaction. Although acetylCoA is formed in both the mitochondria and cytosol, malonyl-CoA is formed only in the cytosol indicating the presence of a pathway that does not involve ATP citrate lyase. The lack of inhibition of the increase in the þ2 isotopomer of malonyl-CoA suggests that in beta cells [U- 13 C]glucose is not metabolized to short chain acyl-CoAs solely in a pathway that involves citrate and the ATP citrate lyase reaction.
3.2. ATP citrate lyase knockdown does not inhibit glucosestimulated insulin release and does not affect the flux of glucose into short chain acyl-CoAs Using more specific and almost complete inhibition of ATP citrate lyase, we studied the ATP citrate lyase stable knockdown cell line ACLY 940-12 [15] . Figure 3 shows that >90% knockdown of ATP citrate lyase enzyme activity in this INS-1 832/13-derived cell line does not inhibit glucose-stimulated insulin release. Figure 4A shows the acetoacetate pathway and the citrate pathways for the incorporation of glucose carbon into acetyl-CoA and malonyl-CoA. With the block at ATP citrate lyase in the citrate pathway, the only pathway for the formation of malonyl-CoA is from the extramitochondrial acetyl-CoA derived from acetoacetate exported from the mitochondria to the cytosol ( Figure 4A ).
Prior to stimulation with glucose or KIC, both cell lines showed similar levels of citrate and acetyl-CoA while the ATP citrate lyase knockdown cell line showed decreased levels of malonyl-CoA and HMG-CoA ( Figure 4D and E). Stimulation with 10 mM [U- 13 C]glucose increased the total levels of citrate and acetyl-CoA equally in both cell lines ( Figure 4B and C) with similar isotopomer distribution. The main isotopomers of citrate were the þ2 isotopomer coming from pyruvate dehydrogenase-derived acetyl-CoA and þ3 isotopomer coming from pyruvate carboxylase-derived oxaloacetate. Acetyl-CoA showed mainly the þ2 isotopomer that is coming from pyruvate dehydrogenase activity in the mitochondria and from the breakdown of acetoacetyl-CoA derived from acetoacetate exported into the cytosol. HMG-CoA levels are known to decrease in pancreatic beta cells after glucose stimulation [19e21] due to the increased flux and consumption into the mevalonate pathway [5] . The level of HMG-CoA decreased in both the control cell line and the ATP citrate lyase knockdown cell line after glucose stimulation. The total amount of HMG-CoA was lower in the knockdown cells most likely because its level in these cells was lower before glucose stimulation ( Figure 4D ). The increase in the malonylCoA concentration and 13 C-glucose incorporation into malonyl-CoA were similar in both cell lines, but the total concentration was less in the knockdown cell line due to the difference in the initial levels prior to stimulation with glucose ( Figure 4E ). Thus, during the course of glucose-stimulated insulin secretion, similar to with hydroxycitrate inhibition, the knockdown of ATP citrate lyase did not prevent the flux of glucose into malonyl-CoA that is formed only in the cytosol and, with knockdown of ATP citrate lyase, can only be formed via the acetoacetate pathway ( Figure 4A ). KIC can stimulate insulin secretion by itself and is also the first intermediate in the leucine metabolism pathway. In the mitochondria, KIC is metabolized into HMG-CoA, which is converted into acetyl-CoA and acetoacetate ( Figure 4A ). [U- 13 C 6 ]KIC increased the þ1 and þ2 isotopomers of acetyl-CoA and malonyl-CoA equally in both the control and the ATP citrate lyase knockdown cell lines ( Figure 4C and E). The þ1 isotopomer of acetyl-CoA and malonyl-CoA is likely coming from the degradation of þ3 labeled cytosolic acetoacetate-derived acetoaceetyl-CoA into two molecules of acetyl-CoA. Although the increase in malonyl-CoA using KIC was much lower than the increase evoked by glucose, it showed increases and isotopomer distribution in the ATP citrate lyase knockdown cell line similar to those of the control cell line. This indicates that cytosolic acetyl-CoA required for malonylCoA formation was coming from the acetoacetate pathway and not from the citrate pathway, as KIC cannot be metabolized to citrate ( Figure 4A ). The HMG-CoA levels in the control and the ATP citrate knockdown cell lines with stimulation with KIC were similar to the HMG-CoA levels in the same cell line without stimulation with KIC or glucose ( Figure 4D ). This extensive labeling of HMG-CoA in both the control cell line and the ATP citrate lyase knockdown cell lines indicates a high rate of flux into the acetoacetate and mevalonate pathways. The total level of HMG was not deceased compared to glucose, because the consumption of HMG was replenished by KIC. the control cells were incubated with [U- 13 C]glucose in RPMI cell culture medium for w16 h. Metabolism was then stopped, and all lipids were extracted and converted into free fatty acid methyl esters and measured using GC/MS. [U- 13 C]glucose incorporation into fatty acids can be determined by measuring the sequential introduction of 2 daltons (coming from acetyl-CoA via malonyl-CoA) into palmitic acid ( Figure 5A ). Before labeling, both cell lines showed similar levels of total palmitic acid ( Figure 5B ). The addition of [U- 13 C 6 ]glucose to the cells revealed a substantial labeling in palmitate in both the ATP citrate lyase knockdown cell line and the control U6 cell line ( Figure 5C ). Although the total amount of palmitate labeling was slightly higher in knockdown cells (Figure 5C ), the percentage of total incorporation of glucose into palmitate was similar between the ATP citrate lyase knockdown cell line and the control cell line confirming that acetyl-CoA and malonyl-CoA can be formed via a pathway redundant to the citrate pathway that requires ATP citrate lyase. The only known redundant pathway is the acetoacetate pathway. acetyl-CoA, acetoacetyl-CoA, malonyl-CoA, and HMG-CoA [4e15]. All of these short chain acyl-CoAs can be generated in the cytosol from glucose after glucose-derived carbon is exported from the mitochondria as citrate or acetoacetate. In the cytosol ATP citrate lyase converts citrate into acetyl-CoA from which other short chain acyl-CoAs can be formed (Figures 2A, 4A and 5A ). Human pancreatic islets have a much lower activity of pyruvate carboxylase required for the citrate pathway than rodent islets or rodent-derived cell lines while human islets still maintain robust glucose-stimulated insulin secretion [9] . ATP citrate lyase knockdown with siRNA technology in INS-1 832/13 cells does not affect glucose-stimulated insulin secretion (15, 17 and Figure 3) , suggesting the presence of a pathway independent of citrate and ATP citrate lyase that beta cells utilize to generate short chain acyl-CoAs. This alternative pathway can only be the acetoacetate pathway shown in Figures 2A, 4A , and 5A.
Glucose flux with inhibition of ATP citrate lyase
The current work shows the redundancy of the ATP citrate lyase reaction using stable isotope labeling and mass spectrometry. ATP citrate lyase activity was lowered using hydroxycitrate to inhibit its enzyme activity by about 70% or by generating an INS-1 832/13-derived cell line with ATP citrate lyase enzyme activity knocked down >90%. This was followed by monitoring the incorporation of carbon from 13 Clabeled glucose into various metabolites. The levels of citrate and acetyl-CoA, as well as the isotopomer distribution in these metabolites, did not change after ATP citrate lyase inhibition with hydroxycitrate ( Figure 2B and D) . However, as these two metabolites are present in both the cytosol and mitochondria, measuring their levels might not clearly show the alternative cytosolic pathway of glucose that can lead to the acetyl-CoA formation. Malonyl-CoA, on the other hand, is formed only in the cytosol, and malonyl-CoA showed no difference in flux from glucose after hydroxycitrate treatment that inhibited ATP citrate lyase ( Figure 2E ). In the cytosol, malonyl-CoA is the precursor for fatty acid synthesis. In the ATP citrate lyase knockdown cells, flux from glucose into malonyl-CoA was substantial, but the unstimulated levels of malonyl-CoA were lower before glucose treatment ( Figure 4E) . Although the absolute level of malonyl-CoA in the ATP citrate lyase knockdown cells was lower before and after the addition of glucose in the ATP citrate lyase knockdown cells, the increase in incorporation of 13 C-glucose carbon into malonyl-CoA ( Figure 4E ) and palmitate ( Figure 5C ) in the ATP citrate lyase knockdown cells after the addition of glucose was similar to that in the control cells. This suggests that the citrate pathway alone, which uses ATP citrate lyase, with or without the assistance from the acetoacetate pathway, maintains malonyl-CoA levels in resting beta cells, but, with glucose stimulation, the acetoacetate pathway is the pathway that supplies short chain acyl-CoAs to the cytosol. This observation is consistent with data from the current study ( Figure 3 ) and previous studies [15, 17] that show that knockdown of ATP citrate lyase does not inhibit glucose-stimulated insulin secretion, but knockdown of acetoacetyl-CoA synthetase [15] and SCOT [10] that catalyze reactions in the acetoacetate pathway does inhibit glucose-stimulated insulin release. HMG-CoA levels showed a pattern similar to malonyl-CoA ( Figure 4D ), where 13 C glucose was significantly incorporated into the HMG-CoA while it showed lower starting levels in the ATP citrate lyase knockdown cells.
a-Ketoisocaproic acid flux with inhibition of ATP citrate lyase
To monitor the flow of carbons not derived from glucose through acetyl-CoA and malonyl-CoA, we used 13 C-labeled KIC. KIC forms HMG-CoA that is then converted to acetyl-CoA and acetoacetate catalyzed by HMG-CoA lyase in the mitochondria. The acetoacetate can then be exported to the cytosol and converted to acetoacetylCoA followed by the other short chain acyl-CoAs ( Figure 4A ). As expected, KIC did not induce any labeling in citrate. However, it caused a significant labeling in acetyl-CoA and malonyl-CoA ( Figure 4C and 4E) . As expected, the levels and labeling of both metabolites were similar between the ATP citrate lyase knockdown and the control cell lines because ATP citrate lyase is not used in the pathway from KIC to cytosolic acetyl-CoA and malonyl-CoA formation. This further implicates the acetoacetate pathway in insulin secretion. HMG-CoA levels in the KIC-stimulated ATP citrate lyase knockdown cells and control cells were similar to their levels in the same cell lines prior to stimulation ( Figure 4D ).
CONCLUSION
The flux of glucose into cytosolic short chain acyl-CoAs was maintained in pure beta cells in the presence of inhibition of ATP citrate lyase with hydroxycitrate and also in a cell line with >90% ATP citrate lyase knockdown suggesting that a pathway other than the citrate pathway is responsible for the flow of carbons into short chain acylCoAs during insulin secretion. The only known pathway other than through the ATP citrate lyase reaction leading to the formation of short chain acyl-CoAs in the cytosol is the acetoacetate pathway ( Figures 4A  and 5A ). In the ATP citrate lyase knockdown beta cell line prior to stimulation with glucose the level of malonyl-CoA was lower compared to the control cell line, but with glucose stimulation the increase in the level of malonyl-CoA and glucose incorporated into malonyl-CoA in the ATP citrate lyase knockdown cell line was similar to that in the control cell line ( Figure 4E ). The results suggest that in resting beta cells the citrate pathway, with or without help from the acetoacetate pathway, maintains short chain acyl-CoA levels in the cytosol, but during insulin stimulatory conditions, such as in the presence of increased concentrations of glucose, the acetoacetate pathway is primarily responsible for supplying cytosolic short chain acyl-CoAs to the cytosol. This idea is consistent with the fact that during glucose stimulation the mitochondrial concentration of succinate increases to high levels and SCOT, which uses succinate as a substrate to form acetoacetate, has a relatively high K m for succinate [10, 15] and, therefore, the acetoacetate pathway can act as a sensor during glucose-stimulated insulin secretion. Glucose incorporation into palmitate in the ATP citrate lyase knockdown cells was even slightly higher in the ATP citrate lyase Figure 5C ). This also supports the idea of an active acetoacetate pathway supplying cytosolic acetyl-CoA and malonyl-CoA during glucose-stimulated insulin secretion.
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